Carbidopa/levodopa - Amneal Pharmaceuticals
Alternative Names: CREXONT; IPX-203; IPX-203 CD/LD extended-release capsules; IPX203 ER; IPX203 ER CD-LD; IPX203 extended-release capsulesLatest Information Update: 27 Sep 2024
Price :
$50 *
At a glance
- Originator Impax Pharmaceuticals
- Developer Amneal Pharmaceuticals; Impax Pharmaceuticals
- Class Antiasthmatics; Antiparkinsonians; Aromatic amino acids; Catecholamines; Hydrazines; Small molecules
- Mechanism of Action Decarboxylase inhibitors; Dopamine receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Parkinson's disease
Highest Development Phases
- Marketed Parkinson's disease